Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis

Sameh Samir Elawady,Rahim Abo Kasem,Bhageeradh Mulpur,Conor Cunningham,Hidetoshi Matsukawa,Mohammad-Mahdi Sowlat,Atakan Orscelik,Noah L A Nawabi,Julio Isidor,Ilko Maier,Pascal Jabbour,Joon-Tae Kim,Stacey Q Wolfe,Ansaar Rai,Robert M Starke,Marios-Nikos Psychogios,Edgar A Samaniego,Shinichi Yoshimura,Hugo Cuellar,Brian M Howard,Ali Alawieh,Ali Alaraj,Mohamad Ezzeldin,Daniele G Romano,Omar Tanweer,Justin R Mascitelli,Isabel Fragata,Adam J Polifka,Fazeel Siddiqui,Joshua W Osbun,Ramesh Grandhi,Roberto Javier Crosa,Charles Matouk,Min S Park,Waleed Brinjikji,Mark Moss,Ergun Daglioglu,Richard Williamson,Pedro Navia,Peter Kan,Reade Andrew De Leacy,Shakeel A Chowdhry,David Altschul,Alejandro M Spiotta,Michael R Levitt,Nitin Goyal
DOI: https://doi.org/10.1136/jnis-2024-021975
2024-08-23
Abstract:Background: A combination of intravenous (IVT) or intra-arterial (IAT) thrombolysis with mechanical thrombectomy (MT) for acute ischemic stroke due to large vessel occlusion (AIS-LVO) has been investigated. However, there is limited data on patients who receive both IVT and IAT compared with IVT alone before MT. Methods: STAR data from 2013 to 2023 was utilized. We performed propensity score matching between the two groups. The primary outcomes were symptomatic intracranial hemorrhage (sICH) and 90-day modified Rankin Scale (mRS) score 0-2. Secondary outcomes included successful recanalization (modified treatment in cerebral infarction (mTICI) ≥2B, ≥2C), early neurological improvement, any intracranial hemorrhage (ICH), and 90-day mortality. Results: A total of 2454 AIS-LVO patients were included. Propensity matching yielded 190 well-matched patients in each group. No significant differences were observed between the groups in either ICH or sICH (odds ratio (OR): 0.80, 95% confidence interval (CI) 0.51-1.24, P=0.37; OR: 0.60, 95% CI 0.29 to 1.24, P=0.21, respectively). Rates of successful recanalization and early neurological improvement (ENI) were significantly lower in MT+IVT + IAT. mRS 0-1 and mortality were not significantly different between the two groups. However, the MT+IVT + IAT group demonstrated superior rates of good functional outcomes (90-day mRS 0-1) compared with patients in the MT+IVT group who had mTICI ≤2B, (OR: 2.18, 95% CI 1.05 to 3.99, P=0.04). Conclusion: The combined use of IAT and IVT thrombolysis in AIS-LVO patients undergoing MT is safe. Although the MT+IVT+ IAT group demonstrated lower rates of recanalization and early neurological improvement, long-term functional outcomes were favorable in this group suggesting a potential delayed benefit of IAT.
What problem does this paper attempt to address?